BIOACTIVE CHEMICAL NUCLEI AS PROMISING SCAFFOLDS FOR ANTICANCER DRUG DEVELOPMENT
Bioactive heterocyclic nuclei remain flexible and clinically proven platforms for the creation of novel anticancer treatments and the integration of bioactive scaffold optimization with precision oncology, computational technologies, biomarker-guided design, and novel target-modulation techniques will be necessary for...